EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Immunotherapeutic Properties of Dexmedetomidine on Pain Management and Cardiovascular Function in Videolaparoscopic Cholecystectomies: A Randomized, Two-Arm, Double-Blinded, Placebo-Controlled Trial

Gustavo Nascimento Silva iD, Virna Guedes Brandão iD, Marcelo Vaz Perez, Sandoval Lage Sobrinho, João Gabriel de Cerqueira Campos Villardi, Priscilla Mendonça do Sacramento, Luiz Claudio Pereira Ribeiro, Rossano Kepler Alvim Fiorelli

Surgical Innovation · 2024

DOI: 10.1177/15533506241234591 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Surgical Innovation, 2024. Verfasst von Gustavo Nascimento Silva und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Gaffrée e Guinle University Hospital, Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazi…. Hauptthemen laut MEDLINE: Dexmedetomidine, Anesthetics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Federal University of the State of Rio de Janeiro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Laparoscopy represented one of the most innovative surgical techniques approached in the surgery field. Dexmedetomidine association with general anesthesia promotes the response control to trauma by altering the neuroinflammatory reflex, provides better clinical outcomes in the postoperative period and reduces the excessive use of drugs with risk for addiction. This trial aims to evaluate the potential drug treatment of dexmedetomidine on organic function, with the targets in neuroinflammation, perioperative pain control and blood pressure measurements in a medium-sized surgical model.

Methods

Fifty-two patients were randomized in two groups: Sevoflurane and Dexmedetomidine – A (dexmedetomidine infusion [1 μg/kg loading, .2-.5 μg/kg/h thereafter]) vs Sevoflurane and Saline .9% - B. Three blood samples were collected at three times: before surgery, 4 to 6 hours after surgery and 24 hours postoperatively. The primary outcome was inflammatory and endocrine mediators dosage analisys. Finally, we evaluated pain and opioid use as secondary outcomes, also the hemodynamic values.

Results

In Dexmedetomidine group A, a reduction of Interleukin 6 was found during 4-6 hours after surgery. A reduction of IL-10 was noted in the measurement of its values 24 hours after the procedure, with statistical significance. Also, systolic and diastolic blood pressure, as well heart rate were attenuated, and there was a lower incidence of pain and opioid consumption in the first postoperative hour ( P < .0001) in the anesthetic recovery room.

Conclusions

Dexmedetomidine provided anti-inflammatory activity, sympatholytic effect and analgesia with cardiovascular safety. It reinforces the therapeutic nature of highly selective α2-adrenergic agonists when combined within anesthetic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexmedetomidineAnestheticsHumansAnalgesics, OpioidPain ManagementSevofluranePostoperative PainCholecystectomyVideo-Assisted SurgeryImmunotherapy

Stichwörter der Autor:innen

cardiovascular functiondexmedetomidineneuroinflammationpainvideolaparoscopic cholecystectomy

Substanzen

DexmedetomidineAnalgesics, OpioidSevofluraneAnesthetics

Autor:innen und Institutionen

  • Department of Anesthesiology, Gaffrée e Guinle University Hospital, Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
  • Department of Surgery and Anesthesia, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
  • Department of General and Specialized Surgery, Gaffrée e Guinle University Hospital, Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
  • Department of Orthopedics, Gaffrée e Guinle University Hospital, Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
  • Microbiology and Parasitology Department, Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
  • Gaffrée e Guinle University Hospital, Federal University of the State of Rio de Janeiro, Rio de Janeiro, Brazil.

ORCID-Profile: Gustavo Nascimento Silva, Virna Guedes Brandão

Förderung

  • Federal University of the State of Rio de Janeiro

Zitieren

APA

Silva, G. N., Brandão, V. G., Perez, M. V., Sobrinho, S. L., Villardi, J. G. C. C., Sacramento, P. M. D., Ribeiro, L. C. P., & Alvim Fiorelli, R. K. (2024). Immunotherapeutic Properties of Dexmedetomidine on Pain Management and Cardiovascular Function in Videolaparoscopic Cholecystectomies: A Randomized, Two-Arm, Double-Blinded, Placebo-Controlled Trial. Surgical Innovation. https://doi.org/10.1177/15533506241234591

Vancouver

Silva GN, Brandão VG, Perez MV, Sobrinho SL, Villardi JGCC, Sacramento PMD, et al. Immunotherapeutic Properties of Dexmedetomidine on Pain Management and Cardiovascular Function in Videolaparoscopic Cholecystectomies: A Randomized, Two-Arm, Double-Blinded, Placebo-Controlled Trial. Surgical Innovation. 2024. doi:10.1177/15533506241234591

BibTeX
@article{Silva2024,
  author = {Silva, Gustavo Nascimento and Brandão, Virna Guedes and Perez, Marcelo Vaz and Sobrinho, Sandoval Lage and Villardi, João Gabriel de Cerqueira Campos and Sacramento, Priscilla Mendonça do and Ribeiro, Luiz Claudio Pereira and Alvim Fiorelli, Rossano Kepler},
  title = {Immunotherapeutic Properties of Dexmedetomidine on Pain Management and Cardiovascular Function in Videolaparoscopic Cholecystectomies: A Randomized, Two-Arm, Double-Blinded, Placebo-Controlled Trial},
  journal = {Surgical Innovation},
  year = {2024},
  doi = {10.1177/15533506241234591}
}
Kostenlos starten →